RxDoctor Payments Data

Sean Bloor, MD

Family Medicine · Columbus, OHNPI 1164981015

Payments from drug & device makers

$7,529in general payments, 2019–2025

Across 441 payments — averaging $17.07 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$1K
  • Viiv Healthcare Company$966
  • AstraZeneca$770
  • Gilead$515
  • Amgen$413
  • Lilly USA, LLC$361
  • plus $3K from 41 others

What the payments were for

  • Food & beverage$7,510100%
  • Education$200%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$7,529 in reported general payments places this provider in the 90th percentile of 3,983 family medicine providers in Ohio.

See all family medicine providers in Ohio

Medicare billing

Part B allowed, 2024
$60,937
Medicare patients
203
Services billed
691

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban58$57,960
JardianceEmpagliflozin26$26,180
TivicayDolutegravir Sodium12$25,354
DescovyEmtricitabine/Tenofov Alafenam12$24,735
JanuviaSitagliptin Phosphate16$13,017
Trelegy ElliptaFluticasone/Umeclidin/Vilanter14$8,884
MyrbetriqMirabegron14$8,690
Breztri AerosphereBudesonide/Glycopyr/Formoterol11$6,884
Praluent PenAlirocumab13$6,434
SymbicortBudesonide/Formoterol Fumarate12$2,815
Lantus SolostarInsulin Glargine,hum.Rec.Anlog16$2,547
Gabapentin149$2,309
Atorvastatin Calcium200$2,070
Tadalafil12$1,701
Sertraline Hcl90$1,625

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$243$57,96058 claims
Boehringer IngelheimJardiance$252$26,18026 claims
Viiv Healthcare CompanyTivicay$966$25,35412 claims
GileadDescovy$515$24,73512 claims
MerckJanuvia$75$13,01716 claims
AstraZenecaBreztri Aerosphere, Symbicort$770$9,69923 claims
GSKTrelegy Ellipta$50$8,88414 claims
Astellas Pharma US IncMyrbetriq$200$8,69014 claims
Amneal Pharmaceuticals LLCLevothyroxine Sodium$15$1,252111 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 3,983 family medicine providers in Ohio.

Other family medicine in Columbus

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →